ONCS - OncoSec Medical - Stock Forecast

Biotechnology & Medical Research - Industry

Coverage Stock analysts Price Targets & Ratings Chart

OncoSec Medical's activity chart (see below) currently has 10 price targets and 9 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 20% of the time, taking 212.33 days on average.

Most recent stock forecast was given by JASON KOLBERT from DAWSON JAMES on 17-Mar-2022.

Best performing analysts who are covering ONCS - OncoSec Medical:

Edward Tenthoff Jason Kolbert Kaveri Pohlman Jason Mccarthy Raghuram Selvaraju

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Jul-2020

$220

4 years 8 months 4 days ago
(17-Mar-2022)

0/1 (0%)

$147.4 (203.03%)

Buy Since 31-Jul-2019

$12

$6

5 years 7 months 27 days ago
(25-Mar-2021)

2/2 (100%)

$-105.7 (-89.80%)

872

Buy Since 15-Oct-2018

$153.85

6 years 11 months 5 days ago
(15-Dec-2019)

1/5 (20%)

$112.93 (275.98%)

402

Hold Since 06-Nov-2018

$220

$1320

8 years 14 days ago
(06-Nov-2018)

0/2 (0%)

$30.8 (16.28%)

Show more analysts

Please expand the browser size to see the chart

What is ONCS (OncoSec Medical) average time for price targets to be met?

On average it took 212 days for the stock forecasts to be reached, with an average price target met ratio of 20%.

Which analyst most recently updated their price target on ONCS (OncoSec Medical)?

Jason Kolbert

Which analyst has the lowest performance score on ONCS (OncoSec Medical) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on ONCS (OncoSec Medical)?

Jason Kolbert works at D. BORAL CAPITAL and has 7 price targets and 8 ratings on ONCS

Which analyst is the currently most bullish on ONCS (OncoSec Medical)?

Jason Mccarthy with the highest potential upside of $264

Which analyst is the currently most reserved on ONCS (OncoSec Medical)?

Jason Kolbert with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?